05/14/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024
4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024
3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/30/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024
3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
|
03/26/2024
7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:22 PM | Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:22 PM | Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:24 PM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:26 PM | Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:11 AM | SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
7:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
7:58 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:08 AM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
12/07/2023
7:50 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/17/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
6:15 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:51 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
2:03 PM | Virpax Pharmaceuticals (Filer)
| Form NT 10-Q | |
10/11/2023
3:10 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:51 AM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:28 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
4:00 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4/A | |
08/16/2023
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
7:14 AM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
06/21/2023
3:16 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:17 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/21/2023
3:18 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy Friday. Sell Monday. (Ad) A 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time.
For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades.
That includes multiple big time winners like 82% from Adobe…
77% from Palo Alto…
But also a barrage of smaller winners like 20% from AMC…
Each of which were opened on a Friday afternoon and closed the very next Monday morning.
As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend. Check it out, simply follow this link here. |
